News

Researchers have identified a promising avenue for therapeutic intervention of sleep apnea, which affects nearly a billion people worldwide.

Scientists are exploring the elaborate interplay between genes, sex, growth, and age and how they influence variation in longevity.

Enrollment has begun in an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. aeruginosa) in their lungs.

Researchers have discovered a rapid and sustainable way to produce a promising anti-cancer compound in the lab. Found naturally only in a single rainforest tree species, the compound can now have expanded availability for research and clinical uses.

A new study has proposed a new approach that may increase the power of drug efficacy testing and pave the way for more personalized cancer therapy.

Scientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations. A single dose produced powerful antidepressant and antianxiety effects in mice that lasted up to two weeks.

Researchers have developed a new, more patient-friendly drug that could revolutionize the way some of the most common gynecological diseases such as fibroids and endometriosis are treated.

A computational platform has been developed that can predict new and specific metabolic targets in ovarian cancer, based on the genetic makeup of a patient's tumor.

Researchers from the University of California, Los Angeles (UCLA) have developed a Zika vaccine technology that is highly effective and safe in preclinical mouse models.

Scientists at MIT have developed a robotic capsule to increase drug absorption by clearing away layers of mucus in the gut and depositing drugs directly on the intestinal surface. This increased the absorption of drugs such as vancomycin and insulin.